Managing the older patient with hypertension

Area of Science:

• Gerontology
• Cardiovascular Medicine
• Pharmacology

Background:

• Elevated systolic blood pressure (SBP) poses a greater cardiovascular risk in elderly individuals compared to diastolic blood pressure.
• Several major clinical trials have investigated the efficacy of antihypertensive therapies specifically in the elderly population.

Purpose of the Study:

• To synthesize findings from major antihypertensive trials in the elderly.
• To identify effective drug classes for managing hypertension in older adults.
• To assess the impact of blood pressure reduction on morbidity and mortality in this demographic.

Main Methods:

• Review and analysis of results from key clinical trials: Systolic Hypertension in the Elderly Program (SHEP), Swedish Trial in Older Patients with Hypertension (STOP-Hypertension), Medical Research Council (MRC) Trial, and Veterans Affairs Cooperative Study Group (VA-CGS).
• Evaluation of specific antihypertensive drug classes for efficacy and tolerability in elderly patients.

Main Results:

• Blood pressure reduction in elderly patients demonstrably decreases morbidity and mortality associated with stroke and cardiac disease.
• Diuretics and calcium antagonists show particular efficacy in treating hypertension in the elderly.
• Beta-adrenergic blockers and angiotensin-converting enzyme inhibitors may be less suitable for this patient group.

Conclusions:

• Antihypertensive therapy is beneficial for reducing cardiovascular events and improving survival in elderly individuals with elevated systolic blood pressure.
• Diuretics and calcium antagonists are recommended as first-line agents for elderly hypertensive patients.
• Elderly patients can generally tolerate effective doses of antihypertensive medications without compromising quality of life.